Recent developments in breach and causation for clinical negligence...
Dec 10 2024
Bevan Brittan Education Lunchtime Training Webinars 2024
Read MoreThe public hearings for Module 1 (preparedness and resilience) of the UK Covid-19 Inquiry have now come to an end, and the Inquiry has announced it expects to publish its report on Module 1 by summer 2024. Although we do not yet know the Inquiry’s view on the evidence given in Module 1, the general picture that unfolded from the hearings – which included witness evidence from household names such as George Osborne, Michael Gove, Matt Hancock and Chris Whitty – was that the UK was ill-prepared for a coronavirus pandemic. Witnesses spent time discussing possible causes for this, and suggestions included the time spent on Brexit, and cuts brought about by austerity measures (those in charge at the time mostly denied both connections). What seems clear is that there will be criticism coming from the inquiry further to this Module’s work on preparedness and resilience so far.
Now that the Module 1 hearings are over, thoughts turn to Module 2 – core UK decision-making and political governance. Public hearings for Module 2 will open on 3 October 2023 (this is a little behind the previously advertised schedule of summer 2023) and will run until December 2023. Modules 2A, 2B and 2C will look at decision-making and governance in Scotland, Wales and Northern Ireland respectively and will begin in early 2024. Core Participant applications are now closed for Module 2.
In early July, the Cabinet Office lost its judicial review claim against the Chair of the Inquiry in relation to her Module 2 notice requiring the Cabinet Office to provide evidence including Boris Johnson’s Whatsapp messages with advisers (particularly those held on Henry Cook’s devices), and Johnson’s diaries. The Cabinet Office argued it should not be compelled to provide this evidence because the Chair’s powers of compulsion under the Inquiries Act did not extend to irrelevant material, that her notice must therefore be limited by reference to relevance, and that the entirety of the material compelled by the Chair under her notice was irrelevant. The Court rejected these arguments, and shortly after the judgment the Chair issued an updated notice to the Cabinet Office requiring unredacted disclosure of the evidence by 10 July 2023. The evidence will now go through a process under the Inquiry’s own redactions protocol in order for the Inquiry to make a judgment about what should be withheld from wider dissemination and/or redacted prior to disclosure to other core participants. The judicial review underlines the wideranging and effective powers of compulsion that the Inquiry enjoys. There will certainly be a lot of public interest in this evidence when the substantive hearings for Module 2 begin.
We now know that the public hearings for Module 3 (healthcare) will take place after the public hearings for Module 4 (vaccines and therapeutics). They are now expected to commence in summer 2024. Module 3 will investigate ‘healthcare governance, primary care, NHS backlogs, the effects on healthcare provision by vaccination programmes as well as Long Covid diagnosis and support’. Core Participant applications are now closed for Module 3.
Public hearings for Module 4 will be taking place prior to those for Module 3. There will be a preliminary hearing for Module 4 on Wednesday 13 September 2023 and we expect the substantive public hearings to begin after that (firm dates have not yet been announced). Core Participant applications are now closed for Module 4.
Module 5 (government procurement) is expected to open in October 2023, with core participant applications accepted between 24 October to 17 November 2023 and public hearings likely to take place in early 2025.
Module 6 (the care sector) is expected to open in December 2023, with core participant applications accepted between 12 December 2023 to 19 January 2024 and public hearings likely to take place in spring 2025.
Future modules in the Inquiry (for which key information has not yet been announced) will cover:
If you would like to discuss this or any other aspect of the Inquiry do please get in touch with Melanie Carter, Partner or Sarah Court-Brown, Senior Associate.
We use necessary cookies to make our site work. We'd also like to set optional analytics cookies to help us improve it. We won't set optional cookies unless you enable them. Using this tool will set a cookie on your device to remember your preferences. For more detailed information about the cookies we use, see our Cookies page.
Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.
We'd like to set Google Analytics cookies to help us to improve our website by collection and reporting information on how you use it. The cookies collect information in a way that does not directly identify anyone.
For more information on how these cookies work, please see our Cookies page.